RENOVARO INC. - COMMON STOCK
0.5535
25-11月-24 08:47:40
15 分の遅延
株式
+0.0345
+6.65%
本日の幅
0.5034 - 0.5535
ISIN
N/A
ソース
NASDAQ
-
Message from Renovaro Biosciences CEO, The Hon. Mark Dybul, MD
02 10 2023 11:05:40 提供 Nasdaq GlobeNewswire
-
AI Company GEDiCube and Renovaro Biosciences Sign Definitive Agreement to Combine
02 10 2023 08:25:00 提供 Nasdaq GlobeNewswire
-
Renovaro Biosciences and AI Health Company GEDi Cube Sign Definitive Agreement to Combine
29 9 2023 08:15:00 提供 Nasdaq GlobeNewswire
-
Renovaro BioSciences Welcomes GEDiCube Announcement of New Joint Effort
30 8 2023 08:15:00 提供 Nasdaq GlobeNewswire
-
Renovaro BioSciences Congratulates GEDi Cube on Appointment of its Chief Medical Officer
21 8 2023 08:15:00 提供 Nasdaq GlobeNewswire
-
09 8 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
Enochian BioSciences Inc. Announces Adjournment of 2023 Annual Stockholder Meeting
23 6 2023 16:00:00 提供 Nasdaq GlobeNewswire
-
08 6 2023 07:45:00 提供 Nasdaq GlobeNewswire
-
Enochian BioSciences’ CEO Letter to Shareholders
03 4 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
29 3 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
Enochian BioSciences Achieves Full Compliance with NASDAQ Filing Requirements
13 3 2023 07:30:00 提供 Nasdaq GlobeNewswire
-
23 2 2023 15:04:00 提供 Nasdaq GlobeNewswire
-
30 11 2022 16:20:12 提供 Nasdaq GlobeNewswire
-
Enochian BioSciences Forges Ahead With Focused Approach, Promising Future
24 10 2022 07:00:01 提供 Nasdaq GlobeNewswire
-
21 10 2022 16:00:00 提供 Nasdaq GlobeNewswire
-
Enochian BioSciences Awarded U.S. Patent For Its Promising Oncology Platform
17 10 2022 07:30:00 提供 Nasdaq GlobeNewswire
-
Enochian BioSciences Appoints Dr. Richard Whitley As Senior Scientific Advisor
25 7 2022 09:15:16 提供 Nasdaq GlobeNewswire
-
Enochian BioSciences Announces Findings From A Rigorous Internal Review of Scientific Data
01 7 2022 16:00:00 提供 Nasdaq GlobeNewswire
-
Scientific Leaders Agree on Promise of Enochian BioSciences
31 5 2022 07:00:00 提供 Nasdaq GlobeNewswire
-
25 5 2022 15:20:30 提供 Nasdaq GlobeNewswire